Quidel | QDEL - 债务



金融业
股票价格
USD
资产
USD 5.72B
现金及等价物
USD 123.4M
销售成本
USD 407M
流动资产
USD 1.38B
流动负债
USD 993.4M
债务
USD 2.87B
EBIT
USD -15.3M
EBITDA
USD 129.3M
员工
6.6K
EPS每股收益
USD -1.27
股本和储备
USD 1.85B
销售毛利
USD 223.9M
债务利息支出
USD 5.63B
利息收入
USD -1.35
贷款资金
USD 2.54B
市值
USD 977.3M
净收入
USD -92.9M
营业费用
USD 646.2M
营业利润
USD -15.3M
普通股股本
USD 68.1M
PE价格收益
2.03
税前利润
USD -79.5M
销售收入
USD 630.9M
销售和管理费用
USD 189.7M
股票
USD 618.9M
贸易债权人
USD 236.5M
应收帐款人
USD 352M


债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Agilent USD 3.35B 0 2025-12
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Bruker USD 1.82B 153.5M 2026-06
Cerus USD 84.16M 791K 2024-12
Charles River Laboratories USD 3.06B 485.84M 2026-03
Danaher USD 26.56B 8.07B 2026-06
Haemonetics USD 1.22B 153K 2026-03
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 16.24B 408M 2026-06
Merit Medical Systems USD 821.56M 9K 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Neogen USD 793.3M 374K 2025-12
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Quidel USD 2.87B 40.8M 2026-03
Revvity USD 3.35B 48.03M 2026-03
STAAR Surgical USD 37.29M 1.06M 2026-03
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Waters USD 5.57B 4.08B 2026-03